Clinical trials

  • Autologous human adipose perivascular stromal cells genetically modified to secrete soluble tumour necrosis factor-related apoptosis-inducing ligand for Pancreatic ductal adenocarcinoma | Locally advanced non-resectable pancreatic adenocarcinoma
  • Nucleic Acid for Heart failure with preserved ejection fraction | Left ventricular hypertrophy
  • PREDNISONE for Erythema multiforme (severe)
  • Fludeoxyglucose (18F) for Histiocytic cell proliferation | Langerhans' cell histiocytosis | Rosai-Dorfman syndrome | Erdheim-Chester disease | Langerhans cell sarcoma
  • LETERMOVIR for Cytomegalovirus infection (post-allogeneic stem cell transplantation)
  • Canakinumab for Myelodysplastic syndromes (lower-risk) | Myelodysplastic/myeloproliferative neoplasm (MDS/MPN) | MDS/MPN-RS-T | MDS/MPNu | Atypical chronic myeloid leukaemia (aCML) | Chronic myelomonocytic leukaemia (CMML)
  • Pembrolizumab for HER2-expressing advanced or metastatic cancers
  • ACETYLSALICYLIC ACID for ST-elevation myocardial infarction
  • Clinical trial in Malignant neoplasm (solid tumors)
  • Vosoritide for Turner syndrome | SHOX deficiency | Noonan syndrome
  • DOCETAXEL for Metastatic squamous cell carcinoma of the anus
  • EPLERENONE for Renal transplant